139 related articles for article (PubMed ID: 16177141)
1. Use of selective serotonin reuptake inhibitors and the risk of breast cancer.
Coogan PF; Palmer JR; Strom BL; Rosenberg L
Am J Epidemiol; 2005 Nov; 162(9):835-8. PubMed ID: 16177141
[TBL] [Abstract][Full Text] [Related]
2. A population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: the impact of duration of use, cumulative dose and latency.
Ashbury JE; Lévesque LE; Beck PA; Aronson KJ
BMC Med; 2010 Dec; 8():90. PubMed ID: 21176215
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant use and colorectal cancer risk.
Coogan PF; Strom BL; Rosenberg L
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1111-4. PubMed ID: 19623565
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen.
Lash TL; Cronin-Fenton D; Ahern TP; Rosenberg CL; Lunetta KL; Silliman RA; Hamilton-Dutoit S; Garne JP; Ewertz M; Sørensen HT; Pedersen L
Acta Oncol; 2010 Apr; 49(3):305-12. PubMed ID: 20156115
[TBL] [Abstract][Full Text] [Related]
5. Use of selective serotonin reuptake inhibitors antidepressants and bleeding risk in breast cosmetic surgery.
Basile FV; Basile AR; Basile VV
Aesthetic Plast Surg; 2013 Jun; 37(3):561-6. PubMed ID: 23571783
[TBL] [Abstract][Full Text] [Related]
6. SSRI use and breast cancer risk by hormone receptor status.
Coogan PF; Strom BL; Rosenberg L
Breast Cancer Res Treat; 2008 Jun; 109(3):527-31. PubMed ID: 17638067
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study.
Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
Breast Cancer Res; 2018 Jan; 20(1):4. PubMed ID: 29351761
[TBL] [Abstract][Full Text] [Related]
8. Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study.
Chen VC; Ng MH; Chiu WC; McIntyre RS; Lee Y; Lin TY; Weng JC; Chen PC; Hsu CY
PLoS One; 2017; 12(3):e0173005. PubMed ID: 28257449
[TBL] [Abstract][Full Text] [Related]
9. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
Furu K; Kieler H; Haglund B; Engeland A; Selmer R; Stephansson O; Valdimarsdottir UA; Zoega H; Artama M; Gissler M; Malm H; Nørgaard M
BMJ; 2015 Apr; 350():h1798. PubMed ID: 25888213
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant medication use and breast cancer risk.
Cotterchio M; Kreiger N; Darlington G; Steingart A
Am J Epidemiol; 2000 May; 151(10):951-7. PubMed ID: 10853633
[TBL] [Abstract][Full Text] [Related]
11. Use of Selective Serotonin Reuptake Inhibitors and Risk of Hip Fracture in the Elderly: A Case-Control Study in Taiwan.
Hung SC; Lin CH; Hung HC; Lin CL; Lai SW
J Am Med Dir Assoc; 2017 Apr; 18(4):350-354. PubMed ID: 28159466
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study.
Bak S; Tsiropoulos I; Kjaersgaard JO; Andersen M; Mellerup E; Hallas J; García Rodríguez LA; Christensen K; Gaist D
Stroke; 2002 Jun; 33(6):1465-73. PubMed ID: 12052976
[TBL] [Abstract][Full Text] [Related]
13. Dose of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding in older adults.
Li YH; Hang LW; Muo CH; Chen SJ; Chen PC
J Psychopharmacol; 2024 Feb; 38(2):137-144. PubMed ID: 38126253
[TBL] [Abstract][Full Text] [Related]
14. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study.
Dalton SO; Johansen C; Mellemkjaer L; Nørgård B; Sørensen HT; Olsen JH
Arch Intern Med; 2003 Jan; 163(1):59-64. PubMed ID: 12523917
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast.
Moorman PG; Grubber JM; Millikan RC; Newman B
Epidemiology; 2003 May; 14(3):307-14. PubMed ID: 12859031
[TBL] [Abstract][Full Text] [Related]
16. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer.
Ashbury JE; Lévesque LE; Beck PA; Aronson KJ
Front Oncol; 2012; 2():177. PubMed ID: 23227451
[TBL] [Abstract][Full Text] [Related]
17. The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants.
Salkeld E; Ferris LE; Juurlink DN
J Clin Psychopharmacol; 2008 Apr; 28(2):230-4. PubMed ID: 18344737
[TBL] [Abstract][Full Text] [Related]
18. Selective Serotonin Reuptake Inhibitors and Risk of Noncardioembolic Ischemic Stroke: A Nested Case-Control Study.
Alqdwah-Fattouh R; Rodríguez-Martín S; Barreira-Hernández D; Izquierdo-Esteban L; Gil M; González-Bermejo D; Fernández-Antón E; Rodríguez-Miguel A; García-Lledó A; Bolúmar F; de Abajo FJ
Stroke; 2022 May; 53(5):1560-1569. PubMed ID: 35109681
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant use and breast cancer risk.
Chien C; Li CI; Heckbert SR; Malone KE; Boudreau DM; Daling JR
Breast Cancer Res Treat; 2006 Jan; 95(2):131-40. PubMed ID: 16322894
[TBL] [Abstract][Full Text] [Related]
20. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
